Zumin Xu
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Angiogenesis and VEGF in Cancer
- Circular RNAs in diseases
- RNA modifications and cancer
- Metabolism, Diabetes, and Cancer
Papers in
-
- Angiogenesis and VEGF in Cancer 4
- Circular RNAs in diseases 3
- Metabolism, Diabetes, and Cancer 2
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Yufang Zuo (14 shared papers)Zhonghua Yu (9 shared papers)Guoquan Gao (7 shared papers)Zhonghan Yang (6 shared papers)Weibin Cai (5 shared papers)Xia Yang (6 shared papers)Donghong Yang (4 shared papers)Zhiyu Dai (4 shared papers)
- Journals
- Oncology Reports (3 papers)Cell Death and Disease (3 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)Technology in Cancer Research & Treatment (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Zumin Xu
23 papers receiving 423 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 141
- Molecular Biology 294
- Oncology 109
- Toxicology 9
- Cell Biology 37
Countries citing papers authored by Zumin Xu
This map shows the geographic impact of Zumin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zumin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zumin Xu more than expected).
Fields of papers citing papers by Zumin Xu
This network shows the impact of papers produced by Zumin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zumin Xu. The network helps show where Zumin Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zumin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 56 | |
| 2 | 2014 | 46 | |
| 3 | 2011 | 36 | |
| 4 | 2018 | 31 | |
| 5 | 2013 | 30 | |
| 6 | 2014 | 28 | |
| 7 | 2016 | 24 | |
| 8 | 2017 | 20 | |
| 9 | 2017 | 20 | |
| 10 | 2011 | 20 | |
| 11 | 2021 | 18 | |
| 12 | 2017 | 15 | |
| 13 | 2015 | 15 | |
| 14 | 2014 | 12 | |
| 15 | 2017 | 12 | |
| 16 | 2009 | 12 | |
| 17 | 2021 | 10 | |
| 18 | 2018 | 8 | |
| 19 | 2022 | 4 | |
| 20 | 2014 | 4 |
About Zumin Xu
Zumin Xu is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 24 papers that have together received 427 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Circular RNAs in diseases (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer-related Molecular Pathways (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Cancer Research (141 citations), Molecular Biology (294 citations), Oncology (109 citations), Toxicology (9 citations) and Cell Biology (37 citations). Zumin Xu has collaborated with scholars based in China and United States. Frequent co-authors include Yufang Zuo, Zhonghua Yu, Guoquan Gao, Zhonghan Yang, Weibin Cai, Xia Yang, Donghong Yang, Zhiyu Dai, Ti Zhou and Shuhuan Fang. Their work appears in journals such as Oncology Reports, Cell Death and Disease, PLoS ONE, Scientific Reports and Technology in Cancer Research & Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.